Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials.
about
Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trialAn Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered MicrobiomeIntestinal microbiota in functional bowel disorders: a Rome foundation reportA randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study).A comparison of irritable bowel syndrome patients managed in primary and secondary care: the Episode IBS study.Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome.Irritable bowel syndrome and chronic fatigue 6 years after giardia infection: a controlled prospective cohort studyGuidelines on the irritable bowel syndrome: mechanisms and practical management.Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome.Markers for visceral hypersensitivity in patients with irritable bowel syndrome.Epidemiology of irritable bowel syndrome.Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome.Evidence-based clinical practice guidelines for irritable bowel syndrome.How to read a clinical trial paper: a lesson in basic trial statistics.IBS and IBD - separate entities or on a spectrum?Motility response to colonic distention is increased in postinfectious irritable bowel syndrome (PI-IBS)Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the ruleComplementary and alternative medicine and mind-body therapies for treatment of irritable bowel syndrome in women.Is irritable bowel syndrome an organic disorder?Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment.Smoking in Irritable Bowel Syndrome: A Systematic Review.Infectious Gastroenteritis as a Risk Factor for Tropical Sprue and Malabsorption: A Case-Control Study.ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS.Chronic diarrhoea.Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.Emotional awareness and expression training improves irritable bowel syndrome: A randomized controlled trial.The Risk of Chronic Gastrointestinal Disorders Following Acute Infection with Intestinal Parasites.Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues.Are symptom-based diagnostic criteria for irritable bowel syndrome useful in clinical practice?Post-infectious IBS: Defining its clinical features and prognosis using an internet-based survey
P2860
Q24595301-58792F7D-02C4-4AA2-9C22-E10F976F6478Q24630575-02D104D4-D746-40E2-AB20-0CCE098DB664Q24631357-0720DAFE-6117-4F5B-881B-F8505AE53F35Q34106923-460CC942-E3E5-479E-B31E-61366BC16ECAQ34247606-DC06B89A-E003-4B90-A311-8944121CC23BQ34301065-16A3E5F4-3C73-43C5-BEB4-963C7E0D11BDQ34393496-2B40BA6D-E515-4C31-BDB4-C651DF6065EDQ34626602-22F5E09A-12C2-44BE-A27D-EC9FACC89466Q34992347-CC5038C0-A4E2-4A93-B75B-31220B85BEA0Q35185813-FEE81D9A-5D78-48E5-88B3-B56274DF7604Q35199242-6644DEDB-F88D-49E0-8A5C-69C23C43E47EQ35216885-007CBE6D-1B67-4D82-A820-DF987A5960B2Q35513973-CBA5CC5C-5C73-41F5-819D-48741DB66224Q36049663-4EBA50F6-42BF-431D-9D9F-58B53469854DQ36144375-FC1F02D6-18E5-4166-9B62-8010E5209226Q36539600-7595B76C-F4D3-462F-A687-86C2F0DC054BQ37169545-E08C320D-676F-42F4-8D3D-390E8650BC95Q38155671-A69FFA93-F3F0-43BD-91CB-EFCA73F32696Q38191561-36B2F9DB-A642-4265-A304-83D99D108192Q38192048-98E4B784-F3BC-4B9D-9FC1-8A348464BBA0Q38727941-4E35FE68-B8D8-4C3A-AD3C-7E8451C74BEBQ39231302-8BB3F872-03BF-49FE-B5CD-0EF2E90B3B51Q41870763-9683AA2C-C13E-4120-8CE5-17F8648B52F0Q42735880-9E011135-A653-4269-A106-4881498FF2FAQ46256357-DD4CB397-830E-4F49-9E1F-5C8D9A8D77DEQ47686007-4F445CDF-C772-4753-82BF-F59AD088DA01Q48504199-224C5720-8CA6-47F9-9718-07CB3AE3A5A2Q51738716-E53AE7AB-2444-4282-A080-E0FFC366A16EQ52971486-85D270FE-FAF1-4161-A5DB-99C66BE92C74Q57063253-C82400E5-7F54-43A3-88AA-923841718D1E
P2860
Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Characteristics of patients wi ...... lications for clinical trials.
@en
Characteristics of patients wi ...... lications for clinical trials.
@nl
type
label
Characteristics of patients wi ...... lications for clinical trials.
@en
Characteristics of patients wi ...... lications for clinical trials.
@nl
prefLabel
Characteristics of patients wi ...... lications for clinical trials.
@en
Characteristics of patients wi ...... lications for clinical trials.
@nl
P2093
P1476
Characteristics of patients wi ...... lications for clinical trials.
@en
P2093
Longstreth GF
Peacock RA
Wiklund IK
P304
P356
10.1046/J.1365-2036.2001.01010.X
P407
P577
2001-07-01T00:00:00Z